Search for: "Deas v. State"
Results 41 - 60
of 659
Sorted by Relevance
|
Sort by Date
4 Aug 2010, 4:27 am
See United States v. [read post]
7 Apr 2023, 6:43 am
Jordan v. [read post]
3 Feb 2019, 11:30 am
Amadis v. [read post]
12 Jul 2017, 12:37 pm
The payment and plan resolve the United States’ allegations that during the period from April 30, 2011, through April 30, 2013, CVS pharmacies failed to provide effective controls and procedures to guard against diversion when CVS allegedly failed to: (1) record the amount received and the date received of Schedule II drugs on DEA-222 Forms; (2) maintain DEA-222 Forms and keep them separate from other records; (3) record the date of acquisition of controlled… [read post]
12 Jul 2017, 12:37 pm
The payment and plan resolve the United States’ allegations that during the period from April 30, 2011, through April 30, 2013, CVS pharmacies failed to provide effective controls and procedures to guard against diversion when CVS allegedly failed to: (1) record the amount received and the date received of Schedule II drugs on DEA-222 Forms; (2) maintain DEA-222 Forms and keep them separate from other records; (3) record the date of acquisition of controlled… [read post]
Judge Rakoff Orders Discovery On Defense Claim of Racially Selective Enforcement By “Reverse Stings”
14 Nov 2019, 2:10 pm
In an Opinion and Order in United States v. [read post]
22 Aug 2020, 8:32 am
Machado Amadis v. [read post]
11 Jul 2012, 8:45 am
United States v. [read post]
25 Jan 2013, 12:41 pm
Petitioners challenged the DEA’s denial of its petition to initiate proceedings to reschedule marijuana as a Schedule III, IV, or V drug. [read post]
7 Aug 2019, 10:43 am
DEA (D.D.C.) -- concluding that DEA properly relied on Exemption 7(E) to withhold two categories of records concerning the Hemisphere Project, a program that collects daily data on telephone calls.Sheppard v. [read post]
17 Nov 2011, 8:32 pm
NOT CHARGED – Possession of Dangerous Drugs for Sale/Misconduct with a Weapon/Possession of Drug Paraphernalia, State v. [read post]
3 Aug 2012, 6:42 am
United States v. [read post]
5 Jul 2023, 8:31 am
Some of the most significant updates include the following: Registration Requirements Generally, every practitioner who dispenses, which includes by definition administering and prescribing, controlled substances in schedules II through V, must be registered with DEA. [read post]
19 Jan 2009, 5:20 am
United States v. [read post]
21 Aug 2010, 7:06 am
United States DOJ DEA, 2010 U.S. [read post]
4 Jul 2012, 9:04 pm
State v. [read post]
29 May 2019, 8:45 am
That’s because last year in Carpenter v. [read post]
18 Sep 2012, 7:59 am
Holder, JR., et al., No. 12-5072 United States Court of Appeals for the District of Columbia Circuit. [read post]
23 May 2019, 6:37 am
Citizen. v. [read post]
8 Oct 2023, 6:46 pm
Instead, DEA states: This extension authorizes all DEA-registered practitioners to prescribe schedule II–V controlled medications via telemedicine through December 31, 2024, whether or not the patient and practitioner established a telemedicine relationship on or before November 11, 2023. [read post]
